From peptide 2° structures to small molecule inhibitors: the Edelris Discovery ENgine (EDEN)

Edelris has pioneered for the past decade the design and synthesis of innovative, natural product-like small molecules (Keymical Collections^TM) and generated its own Keymical Space^TM representing over 8 M cpds. The EDEN platform (Edelris Discovery ENgine) has been developed to combine the leading role of structural information in drug discovery with the attractiveness of our Keymical Space^TM in order to design compounds exploring new boundaries in the modulation of biological systems and particularly to address PPIs.

We will present in this webinar the approach used to design compounds mimicking alpha helix peptide secondary structures. 3D-Pharmacophore data mining using ReCore proved to be successful to discover original and drug-like modulators of the MDM2/P53 interaction.